Thu, Aug 28, 2014, 11:37 AM EDT - U.S. Markets close in 4 hrs 23 mins

Recent

% | $
Quotes you view appear here for quick access.

Dynavax Technologies Corporation Message Board

dnb2020 2 posts  |  Last Activity: Aug 26, 2014 4:39 PM Member since: Apr 16, 1999
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    OK, so what have I missed the past year?

    by dnb2020 Aug 26, 2014 3:50 PM
    dnb2020 dnb2020 Aug 26, 2014 4:39 PM Flag

    Raven, I also respect your evaluation of the stock and the facts...after all we each are investing but may have different views....I did see the stock rise to about $2 and then drop.....my view is that many investors dis not undertand the reverse split news and saw this as weakness that they sold into...more sellers thna buyers=price drop.....I think the biggest dampening on the price is the lack of transparency by DVAX and the conservative nature of their press releases when they do say something.....25K share is a joke for a CEO at under $2pps....he failed at that effort....clarify what you mean by GSK candidate DV....is that our product or a derivative? why should we care when DVAX is being tested and has already proven that it works much better than the current vaccines on the market (albeit in a too small a sample) if you agree with Daum's comments at the previous VRBAC meeting...for those of you not aware Daum was the lead physician that stated the base of DVAX's vaccine was novel and therefore required a much larger sample than is customary to go to the FDA for approval....DVAX scientists either completly missed or ignored this standard and hence that is why we are delayed today.....the vote for approval was within our grasp and that is why I am seeking Raven (a long time "long") to get further insights here......DVAX can go it alone and it can license a distributor in many locations and get huge royalties upon approval....and there are multiple new uses of this vaccine base that will take DVAX from a measly $318M into a $3B market cap....but time is needed at the moment and some insight about the acceptable sample size chosen....and yes Raven it does stink that DVAX wasted another $100M and the pleasure of this delay due to incompetence of the former leadership team...but they are gone now

    Sentiment: Hold

  • First, Raven and CTIC bashing DVAX? Unheard of in the old world order when the stock was breaching $5 pps.....I know, Daum blah blah blah and the lousy share price with the matching delay to redo the trial.....but what really has changed? Nothing but a delay and the perceived risk that an "event" may occur that derails the stock from this lofty 1.45 pps.......ok here is the skinny.....if the vaccine worked before it will test out to work again.....if there are any bumps or "events" then we need to understand what they mean before trashing the price....reverse split? So what.....do you even know what that means? Nothing....less shares at higher price for the same market cap....less shares makes the price rise faster with less supply....I am only concerned that it is taing so darn long for news to be reported and the study results to get underway...there is no fire or passion from the company on any front.....and I am also slightly concerned why the company has not clearly reported that the smaller sampling being done (which is far less than Daum wanted) is acceptable to the FDA in no uncertain terms......this little tea kettle should start to boil again soon

    Sentiment: Hold

DVAX
1.41-0.01(-0.70%)11:35 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.